Ken Fisher’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Sell |
203,654
-1,074
| -0.5% | -$62.6K | ﹤0.01% | 375 |
|
|
2025
Q4 | $11M | Sell |
204,728
-11,414
| -5% | -$549K | ﹤0.01% | 388 |
|
|
2025
Q3 | $9.75M | Sell |
216,142
-10,834
| -5% | -$506K | ﹤0.01% | 412 |
|
|
2025
Q2 | $10.5M | Buy |
226,976
+6,237
| +3% | +$306K | ﹤0.01% | 404 |
|
|
2025
Q1 | $13.5M | Sell |
220,739
-3,138
| -1% | -$183K | 0.01% | 374 |
|
|
2024
Q4 | $12.7M | Sell |
223,877
-2,603
| -1% | -$145K | 0.01% | 406 |
|
|
2024
Q3 | $11.7M | Sell |
226,480
-1,518
| -0.7% | -$71.2K | ﹤0.01% | 400 |
|
|
2024
Q2 | $9.47M | Buy |
227,998
+2,245
| +1% | +$100K | ﹤0.01% | 424 |
|
|
2024
Q1 | $12.2M | Buy |
225,753
+2,322
| +1% | +$118K | 0.01% | 394 |
|
|
2023
Q4 | $11.5M | Buy |
223,431
+126,122
| +130% | +$6.62M | 0.01% | 391 |
|
|
2023
Q3 | $5.65M | Sell |
97,309
-147,884
| -60% | -$9.06M | ﹤0.01% | 509 |
|
|
2023
Q2 | $15.7M | Buy |
245,193
+40,941
| +20% | +$2.75M | 0.01% | 400 |
|
|
2023
Q1 | $14.2M | Buy |
204,252
+5,512
| +3% | +$389K | 0.01% | 408 |
|
|
2022
Q4 | $14.3M | Sell |
198,740
-189,036
| -49% | -$14.3M | 0.01% | 392 |
|
|
2022
Q3 | $27.6M | Sell |
387,776
-38,024
| -9% | -$2.76M | 0.02% | 305 |
|
|
2022
Q2 | $32.8M | Sell |
425,800
-4,011
| -0.9% | -$305K | 0.02% | 263 |
|
|
2022
Q1 | $31.4M | Sell |
429,811
-13,132
| -3% | -$882K | 0.02% | 278 |
|
|
2021
Q4 | $27.6M | Buy |
442,943
+251,210
| +131% | +$14.7M | 0.02% | 290 |
|
|
2021
Q3 | $11.3M | Buy |
191,733
+18,040
| +10% | +$1.19M | 0.01% | 362 |
|
|
2021
Q2 | $11.6M | Sell |
173,693
-1,665
| -0.9% | -$109K | 0.01% | 358 |
|
|
2021
Q1 | $11.1M | Sell |
175,358
-3,783
| -2% | -$235K | 0.01% | 354 |
|
|
2020
Q4 | $11.1M | Buy |
179,141
+3,799
| +2% | +$234K | 0.01% | 351 |
|
|
2020
Q3 | $10.6M | Buy |
175,342
+3,059
| +2% | +$184K | 0.01% | 335 |
|
|
2020
Q2 | $10.1M | Sell |
172,283
-27,191
| -14% | -$1.63M | 0.01% | 333 |
|
|
2020
Q1 | $11.1M | Sell |
199,474
-309,852
| -61% | -$18.9M | 0.01% | 296 |
|
|
2019
Q4 | $32.7M | Sell |
509,326
-7,375
| -1% | -$422K | 0.03% | 225 |
|
|
2019
Q3 | $26.2M | Sell |
516,701
-1,734
| -0.3% | -$81.5K | 0.03% | 254 |
|
|
2019
Q2 | $23.5M | Sell |
518,435
-57,882
| -10% | -$2.7M | 0.03% | 275 |
|
|
2019
Q1 | $27.5M | Buy |
576,317
+82,239
| +17% | +$4.1M | 0.03% | 260 |
|
|
2018
Q4 | $25.7M | Sell |
494,078
-15,165
| -3% | -$815K | 0.04% | 251 |
|
|
2018
Q3 | $31.6M | Sell |
509,243
-72,067
| -12% | -$4.28M | 0.04% | 246 |
|
|
2018
Q2 | $32.2M | Buy |
581,310
+4,229
| +0.7% | +$228K | 0.04% | 242 |
|
|
2018
Q1 | $36.5M | Sell |
577,081
-5,132
| -0.9% | -$330K | 0.05% | 230 |
|
|
2017
Q4 | $35.7M | Buy |
582,213
+77,720
| +15% | +$4.86M | 0.05% | 232 |
|
|
2017
Q3 | $32.2M | Sell |
504,493
-2,534
| -0.5% | -$148K | 0.05% | 232 |
|
|
2017
Q2 | $28.3M | Sell |
507,027
-159,237
| -24% | -$8.67M | 0.04% | 239 |
|
|
2017
Q1 | $36.2M | Buy |
666,264
+12,534
| +2% | +$687K | 0.06% | 203 |
|
|
2016
Q4 | $38.2M | Buy |
653,730
+3,398
| +0.5% | +$186K | 0.07% | 193 |
|
|
2016
Q3 | $35.1M | Buy |
650,332
+2,225
| +0.3% | +$143K | 0.06% | 202 |
|
|
2016
Q2 | $48.9M | Buy |
648,107
+12,047
| +2% | +$851K | 0.09% | 155 |
|
|
2016
Q1 | $43.3M | Buy |
636,060
+501,260
| +372% | +$31.6M | 0.08% | 158 |
|
|
2015
Q4 | $9.27M | Buy |
134,800
+73,620
| +120% | +$4.87M | 0.02% | 306 |
|
|
2015
Q3 | $3.62M | Buy |
61,180
+26,544
| +77% | +$1.68M | 0.01% | 352 |
|
|
2015
Q2 | $2.31M | Buy |
34,636
+2,195
| +7% | +$145K | ﹤0.01% | 374 |
|
|
2015
Q1 | $2.09M | Buy |
32,441
+1,702
| +6% | +$107K | ﹤0.01% | 380 |
|
|
2014
Q4 | $1.81M | Sell |
30,739
-20,462
| -40% | -$1.15M | ﹤0.01% | 385 |
|
|
2014
Q3 | $2.62M | Buy |
51,201
+1,469
| +3% | +$73.4K | 0.01% | 353 |
|
|
2014
Q2 | $2.41M | Buy |
49,732
+33,999
| +216% | +$1.68M | 0.01% | 354 |
|
|
2014
Q1 | $817K | Sell |
15,733
-2,405
| -13% | -$128K | ﹤0.01% | 389 |
|
|
2013
Q4 | $964K | Buy |
18,138
+2,201
| +14% | +$112K | ﹤0.01% | 377 |
|
|
2013
Q3 | $738K | Buy |
15,937
+1,434
| +10% | +$62.9K | ﹤0.01% | 379 |
|
|
2013
Q2 | $648K | Buy |
+14,503
| New | +$630K | ﹤0.01% | 376 |
|
Other funds holding BMY
VCM
VPM
Ken Fisher's BMY Position: Q1 2026 in Review
Ken Fisher reduced its Bristol-Myers Squibb (BMY) stake by 0.52% in Q1 2026, selling an estimated $62.6K and leaving 203,654 shares worth $12.4M. The position accounts for ﹤0.01% of the portfolio, ranked #375.
Ken Fisher first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.9M in Q2 2016. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Ken Fisher held 203,654 shares of Bristol-Myers Squibb worth $12.4M as of Q1 2026.
- Ken Fisher sold 1,074 Bristol-Myers Squibb shares in Q1 2026, an estimated $62.6K.
- Bristol-Myers Squibb made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #375 holding.
- Ken Fisher first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Ken Fisher's Bristol-Myers Squibb position peaked at $48.9M in Q2 2016.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.